Table of Content

1. Executive Summary
   1. Global Lung Cancer Liquid Biopsy Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2024 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Disease Epidemiology
   3. Regulatory Landscape
   4. List of Suppliers
   5. Porter’s Five Forces Analysis
   6. PESTLE Analysis
   7. Promotional Strategies, By Key Players
4. Global Lung Cancer Liquid Biopsy Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024 - 2032
   3. Global Lung Cancer Liquid Biopsy Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
         1. Instruments
         2. Kits and Reagents
         3. Software and Services
      4. Market Attractiveness Analysis: Product
   4. Global Lung Cancer Liquid Biopsy Outlook: Technology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Technology, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
         1. Multi-gene-parallel Analysis (NGS)
         2. Single Gene Analysis (PCR Microarrays)
      4. Market Attractiveness Analysis: Technology
   5. Global Lung Cancer Liquid Biopsy Outlook: Biomarker
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Biomarker, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
         1. Cell-free DNA (cfDNA)
         2. Circulating tumor DNA (ctDNA)
         3. Extracellular Vesicles (EVs)
         4. Circulating Tumor Cells (CTC)
         5. Others
      4. Market Attractiveness Analysis: Biomarker
   6. Global Lung Cancer Liquid Biopsy Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Indication, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
         1. Small Cell Lung Cancer (SCLC)
         2. Non-Small Cell Lung Cancer (NSCLC)
      4. Market Attractiveness Analysis: Indication
   7. Global Lung Cancer Liquid Biopsy Outlook: Sample
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Sample, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
         1. Blood
         2. Cerebrospinal Fluid (CSF)
         3. Plasma
         4. Serum
         5. Others
      4. Market Attractiveness Analysis: Sample
   8. Global Lung Cancer Liquid Biopsy Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By End User, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
         1. Hospitals
         2. Reference Laboratories
         3. Academic & Research Institutes
         4. Others
      4. Market Attractiveness Analysis: End User
5. Global Lung Cancer Liquid Biopsy Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2023
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Lung Cancer Liquid Biopsy Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Technology
      4. By Biomarker
      5. By Indication
      6. By Sample
      7. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Instruments
      2. Kits and Reagents
      3. Software and Services
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
      1. Multi-gene-parallel Analysis (NGS)
      2. Single Gene Analysis (PCR Microarrays)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
      1. Cell-free DNA (cfDNA)
      2. Circulating tumor DNA (ctDNA)
      3. Extracellular Vesicles (EVs)
      4. Circulating Tumor Cells (CTC)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Small Cell Lung Cancer (SCLC)
      2. Non-Small Cell Lung Cancer (NSCLC)
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
      1. Blood
      2. Cerebrospinal Fluid (CSF)
      3. Plasma
      4. Serum
      5. Others
   9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
      1. Hospitals
      2. Reference Laboratories
      3. Academic & Research Institutes
      4. Others
   10. Market Attractiveness Analysis
7. Europe Lung Cancer Liquid Biopsy Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Technology
      4. By Biomarker
      5. By Indication
      6. By Sample
      7. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Instruments
      2. Kits and Reagents
      3. Software and Services
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
      1. Multi-gene-parallel Analysis (NGS)
      2. Single Gene Analysis (PCR Microarrays)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
      1. Cell-free DNA (cfDNA)
      2. Circulating tumor DNA (ctDNA)
      3. Extracellular Vesicles (EVs)
      4. Circulating Tumor Cells (CTC)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Small Cell Lung Cancer (SCLC)
      2. Non-Small Cell Lung Cancer (NSCLC)
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
      1. Blood
      2. Cerebrospinal Fluid (CSF)
      3. Plasma
      4. Serum
      5. Others
   9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
      1. Hospitals
      2. Reference Laboratories
      3. Academic & Research Institutes
      4. Others
   10. Market Attractiveness Analysis
8. East Asia Lung Cancer Liquid Biopsy Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Technology
      4. By Biomarker
      5. By Indication
      6. By Sample
      7. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Instruments
      2. Kits and Reagents
      3. Software and Services
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
      1. Multi-gene-parallel Analysis (NGS)
      2. Single Gene Analysis (PCR Microarrays)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
      1. Cell-free DNA (cfDNA)
      2. Circulating tumor DNA (ctDNA)
      3. Extracellular Vesicles (EVs)
      4. Circulating Tumor Cells (CTC)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Small Cell Lung Cancer (SCLC)
      2. Non-Small Cell Lung Cancer (NSCLC)
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
      1. Blood
      2. Cerebrospinal Fluid (CSF)
      3. Plasma
      4. Serum
      5. Others
   9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
      1. Hospitals
      2. Reference Laboratories
      3. Academic & Research Institutes
      4. Others
   10. Market Attractiveness Analysis
9. South Asia & Oceania Lung Cancer Liquid Biopsy Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Technology
      4. By Biomarker
      5. By Indication
      6. By Sample
      7. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Instruments
      2. Kits and Reagents
      3. Software and Services
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
      1. Multi-gene-parallel Analysis (NGS)
      2. Single Gene Analysis (PCR Microarrays)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
      1. Cell-free DNA (cfDNA)
      2. Circulating tumor DNA (ctDNA)
      3. Extracellular Vesicles (EVs)
      4. Circulating Tumor Cells (CTC)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Small Cell Lung Cancer (SCLC)
      2. Non-Small Cell Lung Cancer (NSCLC)
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
      1. Blood
      2. Cerebrospinal Fluid (CSF)
      3. Plasma
      4. Serum
      5. Others
   9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
      1. Hospitals
      2. Reference Laboratories
      3. Academic & Research Institutes
      4. Others
   10. Market Attractiveness Analysis
10. Latin America Lung Cancer Liquid Biopsy Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Technology
       4. By Biomarker
       5. By Indication
       6. By Sample
       7. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Instruments
       2. Kits and Reagents
       3. Software and Services
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
       1. Multi-gene-parallel Analysis (NGS)
       2. Single Gene Analysis (PCR Microarrays)
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
       1. Cell-free DNA (cfDNA)
       2. Circulating tumor DNA (ctDNA)
       3. Extracellular Vesicles (EVs)
       4. Circulating Tumor Cells (CTC)
       5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
       1. Small Cell Lung Cancer (SCLC)
       2. Non-Small Cell Lung Cancer (NSCLC)
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
       1. Blood
       2. Cerebrospinal Fluid (CSF)
       3. Plasma
       4. Serum
       5. Others
    9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
       1. Hospitals
       2. Reference Laboratories
       3. Academic & Research Institutes
       4. Others
    10. Market Attractiveness Analysis
11. Middle East & Africa Lung Cancer Liquid Biopsy Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Technology
       4. By Biomarker
       5. By Indication
       6. By Sample
       7. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Instruments
       2. Kits and Reagents
       3. Software and Services
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024 - 2032
       1. Multi-gene-parallel Analysis (NGS)
       2. Single Gene Analysis (PCR Microarrays)
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2024 - 2032
       1. Cell-free DNA (cfDNA)
       2. Circulating tumor DNA (ctDNA)
       3. Extracellular Vesicles (EVs)
       4. Circulating Tumor Cells (CTC)
       5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
       1. Small Cell Lung Cancer (SCLC)
       2. Non-Small Cell Lung Cancer (NSCLC)
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2024 - 2032
       1. Blood
       2. Cerebrospinal Fluid (CSF)
       3. Plasma
       4. Serum
       5. Others
    9. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 - 2032
       1. Hospitals
       2. Reference Laboratories
       3. Academic & Research Institutes
       4. Others
    10. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Bio-Rad Laboratories, Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Agilent Technologies, Inc.
       3. Oncocyte Corporation
       4. NeoGenomics Laboratories
       5. Lepu Medical Technology(Beijing)Co.,Ltd
       6. QIAGEN
       7. Thermo Fisher Scientific Inc.
       8. Illumina, Inc.
       9. F. Hoffmann-La Roche Ltd
       10. Sysmex Corporation
       11. BioView
       12. Guardant Health, Inc
       13. SOPHiA GENETICS
       14. BioMark Diagnostics
       15. DELFI Diagnostics, Inc.
       16. Freenome Holdings, Inc.
       17. Foresight Diagnostics, Inc.
       18. Foundation Medicine, Inc.
       19. Pillar Biosciences, Inc.
       20. Caris Life Sciences
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations